Prescribing and Monitoring of Controlled Substances

---

The opioid crisis and an epidemic of chronic pain affects an estimated 100 million Americans. With recent initiatives to change prescribing practices, new models for treating pain need to be explored and considered. The Drug Enforcement Administration (DEA) has issued new requirements for new and renewing DEA licenses starting on June 27, 2023 and physicians will need to complete continuing Medical Education credits to comply with these requirements.

Following the completion of this course, the participant will be able to:

1. Summarize the current substance use disorder (SUD) landscape.
2. Explain the most recent screening and assessment tools available for diagnosis.
3. Describe necessary components of effective treatment planning
4. Discuss common pitfalls surrounding opiate analgesic use.